Antihypertensive drugs and COVID-19

Proposed pharmacological treatments for COVID-19: previously confirmed drugs

Background:     The outbreak of severe acute respiratory syndrome coronavirus-2, also called COVID-19, first appeared in December 2019 in Wuhan, China. COVID-19 is an enveloped single-stranded RNA virus, which has affected more than 14 million people around the world and caused a high rate of mortality. It is notable that discovering new drugs and vaccines against SARS-CoV2 is time consuming. ...

Antihypertensive Drugs

Hypertension is one of the most serious concerns of modern medical practice. It is estimated that in the United States, as many as 60 million people are hypertensive or are being treated with antihypertensive drugs. Among the growing population of elderly Americans, some 15 million have high blood pressure. The level of blood pressure in itself is not a chief concern, since individuals with hig...

Hypertension, antihypertensive drugs and atherosclerosis.

Review of Anti-inflammatory and Immunosuppressive Drugs Used in COVID-19 Epidemic

Introduction: Immunosuppressive drugs are classified into different groups depending on the mechanism of action and are used in the control of acute and chronic inflammatory disorders. Considering the possibility of severe inflammatory complications such as acute respiratory failure and cytokine storm in the patients with COVID-19, there is a need to review the updated data on the effectiveness...

Antihypertensive drugs and plasma lipids.